Non-alcoholic fatty liver disease (NAFLD) is commonly diagnosed in obese subjects;
however, it is not rare among lean individuals. Given the absence of traditional risk factors, it …

Nonalcoholic fatty liver disease (NAFLD) accounts for most cases of chronic liver disease
worldwide, with an estimated global prevalence of approximately 25% and ranges from …

Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease,
encompassing a spectrum from non-alcoholic fatty liver to non-alcoholic steatohepatitis …

Abstract Classically, Non-Alcoholic Fatty Liver Disease (NAFLD) has been thought to be
driven by excessive weight gain and obesity. The overall greater awareness of this disorder …

Data on prevalence and profile of nonalcoholic fatty liver disease (NAFLD) among
individuals who are lean (normal body mass index) is unclear. Published data from studies …

Nonalcoholic fatty liver disease (NAFLD) refers to a group of conditions characterized by
hepatic steatosis in the absence of significant alcohol consumption. NAFLD is seen …

Nonalcoholic fatty liver disease (NAFLD) is commonly diagnosed in obese or overweight
individuals. However, lean individuals with NAFLD are not rare but represent one significant …

Non‐alcoholic fatty liver disease (NAFLD) is one of the most common causes of hepatic
disorders. It represents a wide range of chronic liver diseases in patients with no history of …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, with
an estimated prevalence of 25% globally. NAFLD is closely associated with metabolic …

Non-alcoholic fatty liver disease (NAFLD) parallels comorbidities such as metabolic
syndrome, dyslipidaemia or diabetes. Although NAFLD is very prevalent in overweight …